Most patients with a cardiac resynchronisation therapy (CRT) pacemaker would not benefit from the addition of a defibrillator, according to results from the CeRtiTuDe cohort study presented for the ...

LOS ANGELES — Substituting biventricular (BiV) pacing for standard right ventricular pacing led to significant improvements in survival and hospitalization for heart-failure patients with ...

LAKE OSWEGO, OR —The US Food and Drug Administration today approved the smallest magnetic resonance (MR)–conditional quadripolar cardiac resynchronization pacemaker available in the US, according to a ...

Tim Boreham sharpens his knifes to look under the hood at cardiac pacing device innovator EBR Systems after its US FDA approval. This month, the FDA approved Artrya's (ASX:AYA) arterial plaque ...

The global biventricular pacemakers market is on a sustained growth trajectory, with 2024 revenues estimated at $2.27 billion, building on the $2.1 billion recorded in 2023. Analysts forecast the ...

(MENAFN- PR Newswire) "Recent years have brought significant advancements in leadless pacing for the right heart, but CRT patients were limited to traditional options-until now," said principal ...